]>
IRCT20251101067838N1 IRCT 2025-11-26 Jahrom University of Medical Sciences Studying the effect of using a mobile phone-based medication reminder program and sending educational SMS on medication adherence and quality of life of patients with Acute coronary syndrome After discharge Studying the effect of using a mobile phone-based medication reminder program and sending educational SMS on medication adherence and quality of life of patients with Acute coronary syndrome discharge 2025-11-22 anticipated 66 Complete https://irct.ir/trial/87232 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: In the present study, patients with acute coronary syndrome hospitalized in the cardiology wards of Peymanieh and Seyed Al-Shohada (AS) Hospitals affiliated with Jahrom University of Medical Sciences will be recruited using a convenience sampling method. Patients will be randomly assigned to the intervention group (33 participants) and the control group (33 participants) using the Random Allocation Software. The allocation of each patient will be done individually based on the randomization flowchart generated by the software, Blinding description: The study was single-blinded, meaning that the data collector (research assistant) was unaware of the participants’ group allocation (intervention or control) at each stage. 3 Acute coronary syndrome. Intervention 1: Intervention Group: For patients in the intervention group, in addition to the routine training provided to all patients before discharge, the DaruYad medication-reminder application will be installed on their mobile phones. The DaruYad application was designed by the Biomedical Engineering Department, Faculty of Medical Sciences and Technologies, Science and Research Branch, Islamic Azad University.The various components of the DaruYad software include: the login section, the current medications section, access for the pharmaceutical representative to the patient’s dedicated page, searching the prescribed medication, selecting the medication from the available pharmaceutical company database, and determining the administration instructions for the selected drug.Within the application, the medication dose, dosing interval (every few hours), registration of the first administration time (hour and minute), start date (year, month, and day), dosage form (for example, if the medication is a tablet and half a tablet must be taken), the patient’s medication quota, an audio alarm, and a clear image of the medication’s appearance and specifications are displayed.In addition, patients will receive short reminder text messages for one month after discharge. Intervention 2: Control group: The control group will receive only the routine pre-discharge education provided in the ward, which includes recognizing warning signs, contacting emergency services immediately in case of symptom onset, rest and limitation of physical activity, indications for using nitroglycerin tablets and instructions for their administration, stress management, and appropriate dietary recommendations. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is No further information is available
public Fatemeh Fakharzadeh jahromi
Unit 401, Pars Complex 26, Alley 29/3, Motahari St., Fars Province, Jahrom City
Jahrom Iran (Islamic Republic of) 7167758256 +98 71 5433 2908 f.fakharzadeh@jums.ac.ir Jahrom University of Medical Sciences scientific Dr. Rasoul Eslami Akbar
Jahrom University of Medical Sciences, Motahari Boulevard, Jahrom
jahrom Iran (Islamic Republic of) 7414846199 +98 71 5434 0409 eslamiakbarrasool@ gmail.com Jahrom University of Medical Sciences Iran (Islamic Republic of) Iran (Islamic Republic of) Definite diagnosis of acute coronary syndrome for the first time, confirmed by a cardiologist. No major psychological disorders such as major depression, psychosis, etc. Willingness of the patient to participate in the research. Ability to read and write Ability to use a mobile phone and possession of a personal smartphone capable of installing the medication reminder application used in the present study. Ability to perform self-care activities, especially adherence to prescribed medications. Age between 35 and 65 years No hearing, vision, or other physical and sensory disabilities. No addiction to drugs, alcohol, or psychoactive substances. No memory-related disorders or dementia. No participation in other educational programs or self-care intervention studies. Patient’s acknowledgment of having adequate financial means or family/social support to obtain prescribed medications during the study period. 35 years 65 years Both Recurrence of acute and severe symptoms of the disease or acute complications of coronary syndrome (such as dysrhythmias and various types of heart blocks) requiring rehospitalization in intensive care units. Development of cognitive or psychological disorders during the study. Patient’s unwillingness to continue participation in the study. Death of the patient. Occurrence of acute events or crises affecting medication adherence and the patient’s quality of life, such as severe trauma, death of first-degree relatives, and similar situations. 125.9 Acute coronary Behavior Behavior Intervention Group: For patients in the intervention group, in addition to the routine training provided to all patients before discharge, the DaruYad medication-reminder application will be installed on their mobile phones. The DaruYad application was designed by the Biomedical Engineering Department, Faculty of Medical Sciences and Technologies, Science and Research Branch, Islamic Azad University.The various components of the DaruYad software include: the login section, the current medications section, access for the pharmaceutical representative to the patient’s dedicated page, searching the prescribed medication, selecting the medication from the available pharmaceutical company database, and determining the administration instructions for the selected drug.Within the application, the medication dose, dosing interval (every few hours), registration of the first administration time (hour and minute), start date (year, month, and day), dosage form (for example, if the medication is a tablet and half a tablet must be taken), the patient’s medication quota, an audio alarm, and a clear image of the medication’s appearance and specifications are displayed.In addition, patients will receive short reminder text messages for one month after discharge. Control group: The control group will receive only the routine pre-discharge education provided in the ward, which includes recognizing warning signs, contacting emergency services immediately in case of symptom onset, rest and limitation of physical activity, indications for using nitroglycerin tablets and instructions for their administration, stress management, and appropriate dietary recommendations. Medication adherence. Timepoint: Before, immediately after the intervention, and two months after the intervention. Method of measurement: Morisky Medication Adherence Questionnaire. Quality of life. Timepoint: Before, immediately after the intervention, and two months after the intervention. Method of measurement: MacNew Heart Disease Health-related Quality of Life Questionnaire. Jahrom University of Medical Sciences Approved 2025-10-20 Ethics Committee of Jahrom University of Medical Sciences Deputy for Research and TechnologyوAdministrative (Campus) Building,Jahrom University of Medical Sciences,End of Shahid Motahari Street,Jahrom, Fars Province, Iran jahrom Fars Iran (Islamic Republic of)